Receptor Activator of Nuclear Factor Kappa B (RANK) as a potential therapeutic target in triple-negative breast cancer

被引：0
|
作者：
Reyes, M. E. [1 ]
Masuda, H. [1 ]
Zhang, D. [1 ]
Reuben, J. M. [1 ]
Woodward, W. [1 ]
Darnay, B. G. [1 ]
Hortobagyl, G. N. [1 ]
Ueno, N. T. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-P5-03-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-03-09
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer
    Corkery, B.
    Crown, J.
    Clynes, M.
    O'Donovan, N.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (05) : 862 - 867
  • [2] Potential therapeutic target for triple-negative breast cancer
    Gilbert, Judith A.
    [J]. LANCET ONCOLOGY, 2012, 13 (08): : E330 - E330
  • [3] The nuclear factor kappa B (NF-κB):: A potential therapeutic target for estrogen receptor negative breast cancers
    Biswas, DK
    Dai, SC
    Cruz, A
    Weiser, B
    Graner, E
    Pardee, AB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) : 10386 - 10391
  • [4] Triple-negative breast cancer: investigating potential molecular therapeutic target
    Papa, Anselmo
    Caruso, Davide
    Tomao, Silverio
    Rossi, Luigi
    Zaccarelli, Eleonora
    Tomao, Federica
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (01) : 55 - 75
  • [5] Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer
    Brand, Toni M.
    Iida, Mari
    Dunn, Emily F.
    Luthar, Neha
    Kostopoulos, Kellie T.
    Corrigan, Kelsey L.
    Wleklinski, Matthew J.
    Yang, David
    Wisinski, Kari B.
    Salgia, Ravi
    Wheeler, Deric L.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1356 - 1368
  • [6] CXCL16 as a potential therapeutic target of triple-negative breast cancer
    Cho, Sun Wook
    Jang, Mi Gyeong
    Sun, Hyun Jin
    Lee, Han Sai
    Song, Young Shin
    Kim, Seong Keun
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [7] LRP5: a Potential Therapeutic Target in Triple-negative Breast Cancer
    Maubant, S.
    Maire, V.
    Tesson, B.
    Gentien, D.
    Marty-Prouvose, B.
    Cruzalegui, F.
    Depil, S.
    Tucker, G. C.
    Roman-Roman, S.
    Dubois, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : 161 - 162
  • [8] LRP5: a potential therapeutic target in triple-negative breast cancer
    Maubant, Sylvie
    Maire, Virginie
    Tesson, Bruno
    Gentien, David
    Marty-Prouvost, Berengere
    Cruzalegui, Francisco
    Depil, Stephane
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [9] NOTCH4 Is a Potential Therapeutic Target for Triple-negative Breast Cancer
    Nagamatsu, Iori
    Onishi, Hideya
    Matsushita, Shojiro
    Kubo, Makoto
    Kai, Masaya
    Imaizumi, Akira
    Nakano, Kenji
    Hattori, Masami
    Oda, Yoshinao
    Tanaka, Masao
    Katano, Mitsuo
    [J]. ANTICANCER RESEARCH, 2014, 34 (1A) : 69 - 80
  • [10] Increased expression of folate receptor-α (FRA) in triple-negative breast cancer: A potential therapeutic target
    Crozier, Jennifer A.
    Necela, Brian M.
    Thompson, E. Aubrey
    Geiger, Xochiquetzal
    Moreno-Aspitia, Alvaro
    McCullough, Ann E.
    Pockaj, Barbara A.
    Cunliffe, Heather
    Sun, Zhifu
    Kalari, Krishna R.
    Kachergus, Jennifer M.
    O'Shannessy, Daniel J.
    Maltzman, Julia D.
    Ballman, Karla V.
    Andorfer, Cathy A.
    Perez, Edith A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345